SCHEMBL7979971

SCHEMBL7979971

CC(C)(C)c1ccc2c(c1)nc(Nc1ccccc1Br)c1cncn12

nearest known ligand 0.69

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
LCK P06239 19/20 0.69
LYN P07948 1/20 0.49
BTK Q06187 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7970482 0.87 LCK (0.69) LCKLYNBTK
SCHEMBL7981225 0.85 LCK (0.74) LCKLYNBTK
SCHEMBL7981236 0.83 LCK (0.74) LCKLYNBTK
SCHEMBL7979701 0.83 LCK (0.69) LCKLYNBTK
SCHEMBL7970233 0.80 LCK (0.56) LCKLYNBTK
SCHEMBL7980875 0.80 LCK (0.69) LCK
SCHEMBL7983647 0.79 LCK (0.74) LCKLYNBTK
SCHEMBL7983262 0.78 LCK (0.41) LCK
SCHEMBL7981144 0.76 LCK (0.74) LCKLYNBTK
SCHEMBL7969745 0.75 LCK (0.80) LCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US claimed
WO-1999009845-A1 IMIDAZOQUINOXALINE PROTEIN TYROSINE KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 1999-03-04 WO claimed
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US disclosed